A 28-year-old man presented to the New England Eye Center with a 1-week history of blurry vision, floaters and darkening of his inferior visual field in the right eye.At the time of presentation ...

Johannes Nowatzky; Tova Chajek-Shaul Disclosures Int J Clin Rheumatol. 2009;4 (3):271-286.

"As of the end of August 2023, with 1.5 million vials dosed globally, the estimated reporting rate of retinal vasculitis with occlusion is 0.06/10,000 injections (for retinal vasculitis with or ...

The American Society of Retina Specialists (ASRS) has received reports of at least six cases of occlusive retinal vasculitis following injection of pegcetacoplan (Syfovre) into the eye. In an ...

Key takeaways: A literature search identified 70 eyes with retinal vasculitis or vascular occlusion following brolucizumab for wet age-related macular degeneration. Twenty of 42 eyes experienced ...

Apellis issued updated figures for the number of people who developed retinal vasculitis after receiving its eye medication Syfovre, estimating the rate at 0.01% per injection.

The reported rate of retinal vasculitis with vascular occlusion is 0.06 per 10,000 injections, in line with real-world reported frequencies of other broadly used intravitreal treatments for people ...